Give Hope Blog
Half-matches open door to bone marrow transplant for more patients
May 6, 2019 | Abe Rosenberg
City of Hope doctors have performed more than 250 haploidentical stem cell transplants in the last five years. They are giving more and more patients a new treatment option.
Scientists gaining on graft-versus-host disease
May 2, 2019 | Abe Rosenberg
Scientist Defu Zeng is tackling graft-versus-host disease, a common side effect of bone marrow transplants, taking several tacks that include modulating T cells and fine-tuning specific proteins and antibodies.
Leukemia created a roadblock, music lifted her past it
December 20, 2018 | Zen Vuong
Meet City of Hope 2019 Rose Parade float rider Olivia Gaines, an aspiring songwriter and amateur pianist who has witnessed how music speaks to the heart and calms spirits.
New Clues Could Point to Better Treatments for Chronic Graft-Versus-Host Disease (GVHD)
November 9, 2017 | By Katie Neith
City of Hope’s Defu Zeng, professor of diabetes immunology and hematopoietic cell transplantation and colleagues recently uncovered important information about the chronic GVHD.
Novel Treatment May Stop Graft-Versus-Host Disease
April 18, 2017 | Katie Neith
An international team of researchers led by City of Hope’s Defu Zeng believe they may have found a way to prevent graft-versus host disease following stem cell transplants without sacrificing the transplants’ ability to fight leukemia and lymphoma.
How Couples Can Conquer Cancer Together
February 14, 2017 | Dory Benford
The physical, mental and emotional impact of a cancer diagnosis can shake the foundation of even the most solid relationship, but by communicating openly, working together as a team and developing a new normal, the experience can actually bring couples closer than ever before.
Experts offer guidelines to prevent cardiovascular disease post-transplant
September 30, 2016 | Elise Lamar
Bone marrow transplant survivors have significantly higher rates of cardiovascular disease — such as heart failure, stroke, and heart attacks — compared to the general population. Saro Armenian, D.O., M.P.H., is trying to reverse these outcomes.
Patient's 17-year battle with rare blood cancer won’t dim her spirit
January 12, 2016 | Letisia Marquez
Cheryl Taylor spent New Year’s Day in a brand new way. The City of Hope patient watched the Rose Parade from the grandstands, surrounded by strangers who quickly became friends after she told them she’s battled a rare, debilitating blood cancer – a myeloproliferative neoplasm – for almost 17 years.
Conversation with Tangsheng Yi
March 7, 2012 | City of Hope
The Helix : Tangsheng, give us a brief overview of your paper. Tangsheng Yi : Hematopoietic cell transplantation (HCT) is a curative therapy for hematopoietic malignancies, hereditary hematological disorders and refractory autoimmune diseases.